1,551,844 video views
Loading........
Description: Earn CME: https://naccme.com/program/...

In this presentation from the 'Keeping Up With CAR T-cell Therapies in B-Cell Lymphomas' symposium at the 2019 Great Debates & Updates in Hematologic M...
16:28
Earn CME: https://nacc... In this presentation from the 'Keeping Up With CAR T-cell Therapies in B-Cell Lymphomas' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Matthew J. Frigault discusses best practices for the management of cyto...
by:imedex | 1024 views
19:04
Earn CME: https://www.... In this presentation from the 'Persistent Challenges in the Management of Follicular Lymphoma' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Elizabeth Brem provides and update on the treatment of relapsed/refrac​tory follicular lymphoma. © 2019 Imede...
by:imedex | 361 views
21:28
Earn CME: https://nacc... In this presentation from the 'Persistent Challenges in the Management of Follicular Lymphoma' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. John P. Leonard provides an update on upfront and maintenance the...
by:imedex | 350 views
26:46
Earn CME: https://nacc... In this presentation from the 'Keeping Up With CAR T-cell Therapies in B-Cell Lymphomas' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Caron A. Jacobson discusses the current state of CAR-T therapy in the treatment of lymphoma. © 2019 Imedex, an HMP Com...
by:imedex | 265 views
27:05
Earn CME: https://www.... In this presentation from the 'Confronting the Challenges of Peripheral T-Cell Lymphoma: Genomic Profiling and the Future Treatment Landscape’ symposium at the 2019 Great Debates and Updates in Hematologic Malignancies, Dr. Jasmine Zain discusses nove...
by:imedex | 234 views
19:28
Earn CME: https://nacc... In this presentation from the 'Looking to the Future With Hope: Advances in the Treatment of AML' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Mojtaba Akhtari discusses a patient case to examine whether transplant, conventional therapy, or novel targeted ...
by:imedex | 107 views
20:43
Earn CME: https://nacc... In this presentation from the 'Looking to the Future With Hope: Advances in the Treatment of AML' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Daniel A. Pollyea provides an update on the latest advances in the treatment of acute myeloid leukemia (AML). ...
by:imedex | 167 views
20:42
Earn CME: https://nacc... In this presentation from the 'CLL in the Era of Targeted Therapy' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Richard R. Furman utilizes a case presentation to examine personalized management strategies ...
by:imedex | 152 views
21:18
Earn CME: https://nacc... In this presentation from the 'CLL in the Era of Targeted Therapy' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Jacqueline C. Barrientos discusses therapeutic sequencing in CLL patients, with a focus on mono vs. combination therapy. © 2019 Imedex, an H...
by:imedex | 83 views
27:17
Earn CME: https://nacc... In this presentation from the 'CLL in the Era of Targeted Therapy' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Richard R. Furman discusses novel agents and treatment strategies for patients with chronic lymphocytic leukemia (CLL). © 2019 Imedex, an HM...
by:imedex | 169 views

About imedex
Description: Imedex® has provided the best in accredited, independent continuing medical education for over 25 years. We develop high quality, scientific programs that translate the latest research into clinically relevant information. The programs have a proven sustained impact on disease management, exceptional organization, and outstanding educational value. Imedex is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality, scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management. Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 102,000 live meeting attendees since 2001, Imedex truly educates the global healthcare community. At Imedex, we believe that education is the best medicine.

Links
Channel Url:

Social Links: